SC imposes two-month ban on endosulfan

Image
BS Reporter New Delhi
Last Updated : Jan 20 2013 | 9:33 PM IST

The Supreme Court on Friday imposed a two-month immediate country-wide ban on the production, sale and use of controversial pesticide endosulfan, awaiting the report of an expert committee to study side effects of the chemical. The court said its order was an interim measure in view of the threat perception to human life. It said it was invoking the ‘precautionary principle’ for taking the temporary step.

The principle, enunciated by the court in earlier judgements, said precaution should be taken before sanctioning any action if there would be irretrievable damage to the environment or human life.

The bench headed by Chief Justice S H Kapadia repeatedly observed that “even if one child suffers from the consequences of the pesticide, it should not be our head.” The financial consequences for the manufacturers could be rectified, but the harm done to humans in the interregnum would not be reversible.

The court further directed the statutory authorities in the states to freeze the production licences granted to the manufacturers. The Kerala government has already closed the public sector's Hindustan Insecticide Ltd. There are three other private producers. On their behalf, counsel Mukul Rohtagi prayed they may be allowed to export the chemical. However, the court did not favour it. If the pesticide is bad for the people of Kerala, it must be bad for everyone else, the judges remarked.

In its order passed after examining various reports of expert committees, the court accepted the suggestion of Solicitor General Gopal Subramanium that there should be a fresh study by a joint team. This panel would consist of the director general of the Indian Council of Medical Research and the Agricultural Commissioner. This committee would submit its interim report to the court in July. The next order would depend upon that report. Various earlier reports have reached different conclusions.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 14 2011 | 12:45 AM IST

Next Story